Progress in the Treatment of Central Nervous System Diseases Based on Nanosized Traditional Chinese Medicine
Advanced Science · 2024-04 · 11 (16)
DOI: 10.1002/advs.202308677 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Science, online erschienen am 28.02.2024. Verfasst von Jing Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases, Sch…. Hauptthemen laut MEDLINE: Medicine, Chinese Traditional, Central Nervous System Diseases, Drug Delivery Systems, Blood-Brain Barrier. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 478 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Beijing Natural Science Foundation, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Traditional Chinese Medicine (TCM) is widely used in clinical practice to treat diseases related to central nervous system (CNS) damage. However, the blood‐brain barrier (BBB) constitutes a significant impediment to the effective delivery of TCM, thus substantially diminishing its efficacy. Advances in nanotechnology and its applications in TCM (also known as nano‐TCM) can deliver active ingredients or components of TCM across the BBB to the targeted brain region. This review provides an overview of the physiological and pathological mechanisms of the BBB and systematically classifies the common TCM used to treat CNS diseases and types of nanocarriers that effectively deliver TCM to the brain. Additionally, drug delivery strategies for nano‐TCMs that utilize in vivo physiological properties or in vitro devices to bypass or cross the BBB are discussed. This review further focuses on the application of nano‐TCMs in the treatment of various CNS diseases. Finally, this article anticipates a design strategy for nano‐TCMs with higher delivery efficiency and probes their application potential in treating a wider range of CNS diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases, School of Integrated Chinese and Western Medicine, Hunan University of Ch…
- Beijing Institute of Nanoenergy and Nanosystems, Chinese Academy of Sciences, Beijing, 101400, China.
- Institute of Integrative Medicine, Department of Integrated Traditional Chinese and Western Medicine, Xiangya Hospital, Central South University Changsha, Changsha, 410008, China.
ORCID-Profile: Zhou Li
Förderung
- National Key Research and Development Program of China
- Beijing Natural Science Foundation
- Fundamental Research Funds for the Central Universities
- Science and Technology Innovation Program of Hunan Province
- National Natural Science Foundation of China
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Li, J., Long, Q., Ding, H., Wang, Y., Luo, D., Li, Z., & Zhang, W. (2024). Progress in the Treatment of Central Nervous System Diseases Based on Nanosized Traditional Chinese Medicine. Advanced Science, 11(16). https://doi.org/10.1002/advs.202308677
Vancouver
Li J, Long Q, Ding H, Wang Y, Luo D, Li Z, et al. Progress in the Treatment of Central Nervous System Diseases Based on Nanosized Traditional Chinese Medicine. Advanced Science. 2024;11(16). doi:10.1002/advs.202308677
BibTeX
@article{Li2024,
author = {Li, Jing and Long, Qingyin and Ding, Huang and Wang, Yang and Luo, Dan and Li, Zhou and Zhang, Wei},
title = {Progress in the Treatment of Central Nervous System Diseases Based on Nanosized Traditional Chinese Medicine},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {16},
doi = {10.1002/advs.202308677}
}
EUVIMED